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Abstract
Background—Excessive alcohol consumption is associated with cardiomyopathy, but the 
influence of moderate alcohol use on cardiac structure and function is largely unknown.
Methods and Results—We studied 4466 participants from visit 5 of the Atherosclerosis Risk 
in Communities (ARIC) Study (76±5 years and 60% women) who underwent transthoracic 
echocardiography, excluding former drinkers and those with significant valvular disease. 
Participants were classified into 4 categories based on self-reported alcohol intake: non-drinkers, 
drinkers of up to 7 drinks per week, ≥7 to 14 and ≥ 14 drinks per week. We related alcohol intake 
to measures of cardiac structure and function, stratified by sex, and fully adjusted for covariates. 
In both genders, increasing alcohol intake was associated with larger left ventricular (LV) diastolic 
and systolic diameters and larger left atrial diameter (p values <0.05). In men, increasing alcohol 
intake was associated with greater LV mass (8.2 ± 3.8 g per consumption category, p = 0.029) and 
higher E/E’ ratio (0.82±0.33 per consumption category, p= 0.014). In women, increasing alcohol 
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intake was associated with lower LV ejection fraction (−1.9% ± 0.6% per consumption category, 
p=0.002) and a tendency for worse LV global longitudinal strain (0.45% ±0.25% per consumption 
category, p=0.07).
Conclusions—In an elderly community-based population, increasing alcohol intake is 
associated with subtle alterations in cardiac structure and function, with women appearing more 
susceptible than men to the cardiotoxic effects of alcohol.
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Excessive alcohol consumption is associated with alcoholic cardiomyopathy, characterized 
by enlargement of the heart, increased left ventricular (LV) mass and ventricular 
dysfunction.1 Moreover, alcohol intake has been associated with hypertension, which also 
contributes to alterations in cardiac structure and function2. Conversely, numerous studies 
support a protective association between light to moderate drinking with the risk of coronary 
artery disease (CAD) and even the risk of heart failure (HF).3, 4 However, the cardiovascular 
mechanisms of the risks and potential benefits of alcohol are uncertain.5, 6 Furthermore, the 
variation in the toxic and protective effects of alcohol by sex remains controversial, as 
women may be more sensitive than men to the toxic effects of alcohol on cardiac function, 
developing alcoholic cardiomyopathy at a lower total lifetime dose of alcohol compared to 
men.7
Several echocardiographic morphologic and functional features are known to contribute to 
risk stratification for HF,8 but their association with alcohol consumption in the general 
population, independently of the effects over blood pressure and other factors, is unknown. 
We assessed the associations between alcohol intake and cardiac structure and function, in 
elderly men and women in the large, community-based Atherosclerosis Risk in 
Communities (ARIC) Study.
Methods
Study sample
The overall ARIC Study is an ongoing, prospective observational study. Detailed study 
rationale, design, and procedures have been previously published.9 The original cohort 
included 15 792 men and women aged 45 to 64 years recruited between 1987 and 1989 
(visit 1), selected from 4 communities in the United States: Forsyth County, North Carolina; 
Jackson, Mississippi; Minneapolis, Minnesota; and Washington County, Maryland. 
Subsequently, three follow-up visits (visit 2 to 4) occurred at 3-year intervals, with annual 
telephone interviews conducted between visits. Between 2011 and 2013, 6118 surviving 
participants performed echocardiography during Visit 5, in all 4 ARIC field centers. 
Institutional review boards from each site approved the study, and informed consent was 
obtained from all participants.
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Our analyses were restricted to the participants who were self-described as black or white 
(n=6102). We excluded participants without alcohol consumption data (n=149), those 
classified as former drinkers (n=1459) and those with moderate to severe valvular disease 
(n=28). A total of 4466 participants, 1781 men and 2685 women constitute the sample for 
the present analysis.
Measurements
Alcohol Consumption—Alcohol consumption was ascertained at all visits by means of 
an interviewer-administered questionnaire. Subjects were asked if they currently drank 
alcoholic beverages and, if not, whether they had done so in the past. Current drinkers were 
asked how often they usually drank wine, beer, or liquor per week. In calculating the amount 
of alcohol consumed (in grams per week), it was assumed that 4 ounces (118 ml) of wine 
contains 10.8 g, 12 ounces (355 ml) of beer contains 13.2 g, and 1.5 ounces (44 ml) of liquor 
contains 15.1 g of ethanol. Subsequently, grams of ethanol were converted to drinks per 
week (14 g of alcohol= 1 drink) and participants were classified into 4 categories, as in prior 
publications,6 according to their alcohol consumption at visit 5: non-drinkers, drinkers of up 
to 7 drinks per week, ≥7 to 14 and ≥ 14 drinks per week. Non drinking participants at visit 5, 
who had reported alcohol consumption in visits 1 to 4, were classified as former drinkers 
and excluded from the analysis. Alcohol consumption measured at visit 5 was used as 
primary exposure variable in the analysis. In addition, we estimated cumulative average 
alcohol intake using data acquired from questionnaire responses at all visits, for a mean time 
exposure of 23.6±0.9 years. The calculation of this variable included the estimation of 4 
separate time intervals (visit 1 to visit 2; visit 2 to visit 3, etc.). For each time interval, we 
estimate the average alcohol consumption by averaging the consumption levels reported at 
the beginning and end of the interval. We then take a weighted average of the 4 interval 
estimates, weighting according the number of days elapsed between the two visits. If a 
participant was missing alcohol consumption for a certain visit, the measurements from the 
available years were averaged. Cumulative average alcohol intake was also converted to the 
previously described 4 categories of drinks per week.6
Echocardiography Protocol—The echocardiographic imaging and analysis protocol has 
been previously described in detail.10 All echocardiograms were performed using dedicated 
Philips iE33 Ultrasound systems with Vision 2011, using a preprogrammed acquisition 
protocol. All studies were acquired and stored digitally and transferred from field centers to 
a secure server at the Corelab, the Echocardiography Reading Center (ERC; Brigham and 
Women’s Hospital, Boston, MA), where echocardiographic measures were performed and 
over read, using proprietary validated echocardiographic analysis software.
All echocardiograms were obtained in a manner most consistent with good clinical practice, 
recording ≥3 full cardiac cycles for each view for patients in sinus rhythm and 1 or more 5-
second acquisitions per view, for subjects in atrial fibrillation. LV dimensions, wall 
thickness, anteriorposterior left atrial (LA) dimension, and outflow tract diameter were 
measured from the parasternal long-axis view according to the recommendations of the 
American Society of Echocardiography (ASE).11 LV mass was calculated from LV linear 
dimensions and indexed to body surface area as recommended by ASE guidelines. LV 
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hypertrophy was defined as LV mass indexed to body surface area (LV mass index) >115 
g/m2 in men or >95 g/m2 in women. Relative wall thickness was calculated from LV end-
diastolic dimension and posterior wall thickness. LV volumes were calculated by the 
modified Simpson method using the apical 4- and 2-chamber views, and LV ejection 
fraction was derived from volumes in the standard manner. LA volume was measured by the 
method of disks using apical 4- and 2-chamber views at an end-systolic frame preceding 
mitral valve opening. Early transmitral velocity (E-wave) was measured by pulsed-wave 
Doppler from the apical 4-chamber view with the sample volume positioned at the tip of the 
mitral leaflets. Peak lateral and septal mitral annular relaxation velocities (E′) were assessed 
using tissue Doppler imaging12 and LV diastolic function classified according to Olmsted 
criteria.13 Right ventricular (RV) function was assessed using the tricuspid annular peak 
systolic velocity measured from the lateral tricuspid annulus, and RV fractional area change 
was calculated as the percent change in cavity area from end-diastolic to end-systolic 
tracings of the RV cavity in the apical 4-chamber view. Peak tricuspid regurgitation velocity 
was measured and peak RV-to-right atrial systolic gradient was calculated as 4×(peak 
tricuspid regurgitation velocity).
Deformation analysis was performed using the TomTec Cardiac Performance Analysis 
package. Analysis was performed on 2D images acquired at a frame rate of 50 to 80 frames 
per second. Longitudinal strain was measured by tracing the endocardial borders in the 
apical 4-chamber and 2-chamber views. Peak longitudinal strain and strain rate were 
computed automatically, generating regional data from 6 segments and an average value for 
each view.
Measurement of Other Baseline Covariates—Standardized and validated 
interviewer-administered questionnaires included assessment of smoking, current 
medication, the presence of CAD or diabetes. Interviews included assessment of annual 
income and educational level, with high education defined as any college or graduate or 
professional school attendance. Information on demographics, anthropometric measures, and 
blood pressure was obtained at the time of echocardiography. Established definitions for 
hypertension, obesity, diabetes mellitus, CAD, and smoking status were used as previously 
described in the ARIC study.14 Total cholesterol, high-density lipoprotein cholesterol (HDL) 
and triglycerides levels were measured in a centralized laboratory and subsequently low-
density cholesterol (LDL) was calculated. The assays and their performance have been 
previously reported.15 For the purpose of this study, results from Visit 5 were considered.16
Statistical methods—The analyses were performed overall and separately for each sex. 
For the 4 groups (non drinkers, up to 7 drinks per week, ≥7 to 14 and ≥14 drinks per week), 
summary statistics for covariates were calculated as counts and percentages or means and 
standard deviation for categorical and continuous data, respectively. Comparisons of 
baseline characteristics between the 4 groups were made using trend tests by regression 
methods and chi-squared tests for trend for continuous and dichotomous variables, 
respectively.
Using multivariate linear and logistic models, we examined separately the association of 
both alcohol intake at visit 5 and cumulative average alcohol intake, with measures of 
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cardiac structure and function, stratified by sex, and adjusted for three different models: 
Model 1, which included age, body mass index (BMI), diabetes, anti-hypertensive 
medication, systolic blood pressure and previously diagnosed myocardial infarction; Model 
2, which included Model 1 variables, plus education, income level and cigarette smoking in 
all visits and Model 3, including Model 2 variables with body size represented by BSA 
instead of BMI. The primary analysis variable was the alcohol consumption measured at 
visit 5 and the main results are presented according to Model 2. The analysis with the 
cumulative average alcohol consumption was performed as sensitivity analysis. In addition 
to the test for trend across alcohol consumption categories, we also tested for multivariate 
linear and curvilinear association between the continuous measure of alcohol consumption at 
baseline and measures of cardiac measures of cardiac structure and function. In the presence 
of non-linear associations, we used a restricted cubic spline model with the number of knots 
chosen on the basis of maximizing goodness of fit (i.e. minimizing AIC). Tests for 
interaction were performed using the likelihood ratio test comparing models with and 
without interaction terms between either sex or race and the continuous visit 5 drinking 
status variable(s). Two-sided p values <0.05 were considered significant. Analyses were 
performed using Stata version 13.1 (Stata Corp., College Station, Texas).
Results
The final analysis dataset included 4466 participants with a mean age of 76±5 years and 
approximately 54% of subjects reported no alcohol consumption. Overall 2685 (60%) were 
women and 873 (20%) were black. Table 1 illustrates the characteristics of the study 
population according to categories of alcohol intake at visit 5. Non-drinkers were more 
likely to be women with higher BMI, and non drinkers of both genders were older, had 
lower education level and lower annual income, and were more likely to be diabetic, to have 
lower LDL and HDL cholesterol and higher TG/HDL ratio. Drinkers of ≥14 drinks per week 
of both sexes were more frequently smokers and had higher LDL and HDL cholesterol. The 
relationship between alcohol consumption and hypertension was U-shaped in both genders, 
with hypertension being more frequent among non-drinkers and in those participants 
drinking ≥14 drinks per week. There was no significant trend in the prevalence of CAD by 
category of alcohol intake.
Increasing alcohol intake was associated with larger LV diastolic and systolic diameter and 
larger LA diameter in men and in women (Table 2). Among men, increasing alcohol intake 
was associated with greater LV mass, higher E/E’ ratio and tricuspid annulus peak systolic 
velocity and a tendency for larger RV diastolic area. In woman, increasing alcohol intake 
was associated with lower LV ejection fraction and a propensity towards worse peak 
longitudinal LV strain and increased time to peak longitudinal LV strain (Table 3). In spite 
of increasing LV end diastolic diameter, no significant increase in LV volumes was 
observed in either men or women according to alcohol intake.
The linear association between the continuous measurement of alcohol consumption and LV 
end diastolic diameter and LV mass confirmed the results obtained by the multivariate linear 
model (Figure 1). In addition we observed a significant reduction in LV relative wall 
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thickness, by increasing alcohol intake and a higher prevalence of LV hypertrophy in men 
with higher alcohol consumption (Table 2).
We observed a significant interaction between sex and alcohol intake with respect to LV 
ejection fraction (p = 0.03) and tricuspid annulus peak systolic velocity (p=0.002), in 
addition to a nominal association in the interaction with respect to peak systolic longitudinal 
strain (p=0.08) (Table 3 and Figure 2), with women demonstrating worse LV and RV 
function for any given degree of alcohol consumption, compared with men. We found no 
significant differences in diastolic function categories classification, according to alcohol 
consumption, but drinkers of ≥14 drinks per week were less likely to have mild diastolic 
dysfunction (DD) and more prone to have moderate-severe (DD). However, 19% of 
participants were unclassifiable according to Olmsted criteria.
We observed a significant interaction between race and alcohol intake in men only for LV 
end-diastolic diameter, with greater increases in LV end-diastolic diameter in black men 
than in white men, for the same amount of alcohol intake (p = 0.008) (Supplemental Figure). 
However, the limited number of black participants, particularly in the highest drinking 
category, 14 (9.5%) men and 3 (6.4%) women, might have limited the power to estimate 
potential differences by race.
Discussion
In the present study alcohol intake was independently associated with larger LV diastolic 
and systolic diameter and larger LA diameter in men and in women. Among men, increasing 
alcohol intake was associated with greater LV mass, higher E/E’ ratio and higher tricuspid 
annulus peak systolic velocity. In women, increasing alcohol intake was linearly associated 
with lower LV ejection fraction, and there was a propensity for worse peak longitudinal LV 
strain.
Alcohol is a known dose-dependent cardiac toxin, but myocardial damage may be a 
consequence of direct toxic effects of alcohol or its metabolites by ethanol induced 
apoptosis;17 associated hypertension,18 coexisting nutritional deficiencies, or, rarely, toxic 
additives to alcoholic beverages.19 Alcoholic cardiomyopathy is characterized by 
enlargement of the heart, increased LV mass and ventricular dysfunction,1 besides, total 
lifetime dose of ethanol correlates inversely with LV ejection fraction and directly with LV 
mass.20 Subtle signs of cardiac abnormalities as LV dilatation and impaired LV relaxation 
have also been reported in chronic asymptomatic heavy drinkers21 and prior small studies 
have described depression of LV contractility by acute alcohol consumption, evaluated by 
ejection fraction22 or by global longitudinal strain, which may allow detection of earlier 
stages of LV dysfunction.23 Similarly, reversible myocardial injury has been reported after 
binge drinking in healthy volunteers, with myocardial hyperenhancement demonstrated on 
magnetic resonance imaging.23 However, in spite of the awareness of alcohol induced LV 
injury and dysfunction by heavy alcohol intake, associations between alcohol consumption 
and measures of cardiac structure and function in the general population are mostly 
unknown.
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In this study, of an elderly community-based cohort, we found that alcohol intake was 
independently associated with larger LA and LV diameters, in both men and women, and 
with increasing LV mass among men. In patients with CAD, heavier alcohol consumption 
has been associated with a 5-year increase in LA volume,24 but the association between LA 
dimensions and alcohol consumption in the community was generally unknown. Left atrial 
enlargement is a robust predictor of cardiovascular outcomes25 and it has been associated 
with the incidence and prevalence of HF with reduced and preserved LV ejection fraction.26 
Similarly, LV mass is strongly associated with incidence of cardiovascular disease and 
death.27 Our results are consistent with those reported with respect to LV mass in the 
Framingham Study, as alcohol intake was positively associated with LV mass in men but not 
in women.28 Moreover, alcohol intake was associated with higher E/E’ ratio among men, 
suggesting increasing LV diastolic pressures.
Men had better measurements of RV systolic function with increasing alcohol intake, in 
contrast to women. There is limited data on the effects of alcohol on RV function, but it has 
been reported that low doses of alcohol in normal healthy individuals may lead to dilation of 
RV end-diastolic diameter and to an acute increase in some indices of RV function.29 
Conversely, studies on dogs reported that moderate or high doses of alcohol were associated 
with RV myocardial dysfunction in a dose-dependent manner.30
The sex-related differences in the association between alcohol intake and echocardiography 
measures of structure and function cannot be explained by differences in age, body mass 
index or body surface area, current anti-hypertensive treatment, systolic blood pressure, 
prevalence of diabetes or CAD, socio-economic status or smoking. They also cannot be 
plausibly explained by gender differences in alcohol intake reporting, as we observed 
consistent positive associations between alcohol intake and HDL levels, a biological marker 
of alcohol consumption,31 in both men and women. Similarly, the TG/HDL ratio, a predictor 
of cardiovascular disease and known to be inversely associated with alcohol drinking,32 
decreased with alcohol consumption in both men and women. There are a number of 
different mechanisms by which the effects of alcohol on the heart may differ by sex. Women 
absorb and metabolize alcohol differently than men33 and women seem to be more sensitive 
than men to the toxic effects of alcohol on cardiac function, developing alcoholic 
cardiomyopathy with a lower total lifetime dose of alcohol compared with men.734 
Consistent with these findings, our study shows associations between alcohol intake and 
subclinical changes in cardiac structure in both sexes; although only among women 
increasing alcohol intake was associated with reduction of LV and RV systolic function. 
Interestingly, while we observed the classic U-shaped relationship between alcohol 
consumption and hypertension,2 there was no threshold for alcohol protection, when 
associated with measures of cardiac structure and function in this cohort. However, the 
possibility that the effects of alcohol consumption may be partly mediated by increased 
blood pressure cannot be ruled out. In addition, alcohol affects sex hormones metabolism,35 
which have been associated with cardiac morphology and function, particularly, higher 
levels of androgens were associated with greater RV mass and volumes in both sexes. Thus, 
the part of sex hormones in the sex-related differences in the association between alcohol 
intake and cardiac structure and function cannot be excluded.36
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A number of limitations should be noted. This is an observational study and alcohol 
consumption was self reported in a questionnaire administered by an interviewer, thus 
participants may have underreported their consumption level. Our population only includes 
participants older than 65 years old, and the number of black participants was too small for 
interpretation of race related differences. Therefore our observations may not be 
generalizable to other populations. As in any observational study, potential confounding by 
unmeasured factors can contribute to biased estimates, and the associations observed 
between alcohol consumption and subclinical changes of cardiac structure and function 
cannot be assumed to be causal, hence our results should be interpreted accordingly.
The strengths of this study include its large size, the ability to control for cardiovascular risk 
factors, CAD, socio-economic status and demographic factors. Moreover, we analyzed 
associations by time updated cumulative average alcohol consumption during 23.6±0.9 
years, we excluded former drinkers, minimizing the potential bias due to drinking cessation 
because of illness, and we were able to analyze sex specific differences in the association of 
alcohol intake and measures of cardiac structure and function. In addition, we followed a 
rigorous echocardiographic protocol utilizing modern echocardiographic techniques.
In summary, we found that increasing alcohol intake in among the elderly is associated with 
mild alterations in cardiac structure and function. In women, moderate alcohol consumption 
was associated with modest reduction in systolic function, potentially contributing to a 
higher risk of alcoholic cardiomyopathy, for any given level of alcohol intake.
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Clinical Perspective
In this elderly community-based population, increasing alcohol intake was associated 
with subtle alterations in cardiac structure and function. In women, moderate alcohol 
consumption was associated with modest reduction in systolic function, potentially 
contributing to a higher risk of alcoholic cardiomyopathy, for any given level of alcohol 
intake. There are a number of different mechanisms by which the effects of alcohol on 
the heart may differ by sex. Women absorb and metabolize alcohol differently than 
men33 and women seem to be more sensitive than men to the toxic effects of alcohol on 
cardiac function, developing alcoholic cardiomyopathy with a lower total lifetime dose of 
alcohol compared with men.734 Consistent with these findings, our study shows 
associations between alcohol intake and subclinical changes in cardiac structure in both 
sexes; although only among women increasing alcohol intake was associated with mild 
reduction of ventricular systolic function. In consequence, this study gives strength to the 
differences in the sensitivity of toxic alcohol effects by sex, which is in agreement with 
the international recommendations for a lower threshold of alcohol consumption in 
women compared to men.
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Figure 1. Multivariate analysis of morphological echocardiography characteristics, as a function 
of alcohol intake, by sex
Multiple linear regression analysis models with 95% confidence intervals indicated by the 
dashed lines. Models are adjusted for age, body mass index, diabetes, previously diagnosed 
myocardial infarction, anti-hypertensive treatment, systolic blood pressure, education, 
income level and cigarette smoking in all visits. P for overall relationship is shown. Blue 
lines represent men, red lines represent women. In men and women, LV end diastolic 
diameter and LV mass increase and LV relative wall thickness reduces, by alcohol intake.
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Figure 2. Multivariate analysis of functional echocardiography characteristics, as a function of 
alcohol intake by sex
Multiple linear regression analysis models with 95% confidence intervals indicated by the 
dashed lines. Models are adjusted for age, body mass index, diabetes, previously diagnosed 
myocardial infarction, anti-hypertensive treatment, systolic blood pressure, education, 
income level and cigarette smoking in all visits. P values represented for overall relationship 
by sex and for interaction between sex and alcohol intake. Blue lines represent men, red 
lines represent women. Women present worse LV and RV function for any given degree of 
alcohol consumption, compared with men.
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